These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 39322385)
1. Familial cerebral amyloid disorders with prominent white matter involvement. Banerjee G; Schott JM; Ryan NS Handb Clin Neurol; 2024; 204():289-315. PubMed ID: 39322385 [TBL] [Abstract][Full Text] [Related]
2. Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias. Michno W; Koutarapu S; Camacho R; Toomey C; Stringer K; Minta K; Ge J; Jha D; Fernandez-Rodriguez J; Brinkmalm G; Zetterberg H; Blennow K; Ryan NS; Lashley T; Hanrieder J J Neurochem; 2022 Nov; 163(3):233-246. PubMed ID: 36102248 [TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease. Ryan NS; Biessels GJ; Kim L; Nicholas JM; Barber PA; Walsh P; Gami P; Morris HR; Bastos-Leite AJ; Schott JM; Beck J; Mead S; Chavez-Gutierrez L; de Strooper B; Rossor MN; Revesz T; Lashley T; Fox NC Neurobiol Aging; 2015 Dec; 36(12):3140-3151. PubMed ID: 26410308 [TBL] [Abstract][Full Text] [Related]
4. Cerebral amyloid angiopathy and dementia. Tian J; Shi J; Mann DM Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981 [TBL] [Abstract][Full Text] [Related]
5. Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models. Kumar-Singh S Int J Mol Sci; 2009 Apr; 10(4):1872-1895. PubMed ID: 19468344 [TBL] [Abstract][Full Text] [Related]
6. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. Kumar-Singh S Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371 [TBL] [Abstract][Full Text] [Related]
7. Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome. Kasri A; Camporesi E; Gkanatsiou E; Boluda S; Brinkmalm G; Stimmer L; Ge J; Hanrieder J; Villain N; Duyckaerts C; Vermeiren Y; Pape SE; Nicolas G; Laquerrière A; De Deyn PP; Wallon D; Blennow K; Strydom A; Zetterberg H; Potier MC Acta Neuropathol; 2024 Jul; 148(1):8. PubMed ID: 39026031 [TBL] [Abstract][Full Text] [Related]
8. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy. Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731 [TBL] [Abstract][Full Text] [Related]
9. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice. Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504 [TBL] [Abstract][Full Text] [Related]
10. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers. Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462 [TBL] [Abstract][Full Text] [Related]
13. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Mann DM; Pickering-Brown SM; Takeuchi A; Iwatsubo T; Am J Pathol; 2001 Jun; 158(6):2165-75. PubMed ID: 11395394 [TBL] [Abstract][Full Text] [Related]
16. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Chalmers K; Wilcock GK; Love S Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320 [TBL] [Abstract][Full Text] [Related]
17. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Zhang-Nunes SX; Maat-Schieman ML; van Duinen SG; Roos RA; Frosch MP; Greenberg SM Brain Pathol; 2006 Jan; 16(1):30-9. PubMed ID: 16612980 [TBL] [Abstract][Full Text] [Related]
18. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice. Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of familial cerebral amyloid angiopathy mutant amyloid beta-protein fibril assembly by myelin basic protein. Hoos MD; Ahmed M; Smith SO; Van Nostrand WE J Biol Chem; 2007 Mar; 282(13):9952-9961. PubMed ID: 17259179 [TBL] [Abstract][Full Text] [Related]
20. White matter hyperintensities: relationship to amyloid and tau burden. Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]